Concepedia

A. Seshaadri

AS

Statistics

Publications

4

Citations

220

H-Index

4

Active since

2008

Affiliations

Roche (United States)(Current)

A. Seshaadri is an author at Roche (United States) specializing in molecular virology, virology, and antiviral resistance.

Publications per year

2008–2010

4

Publications

4

Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients

Sophie Le Pogam, A. Seshaadri, Alan Kosaka et al. · Journal of Antimicrobial Chemotherapy · 2008 · 134 citations

Life Sciences, Genetics, Pharmacology +17

RG7128 Alone or in Combination with Pegylated Interferon‐α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV‐Infected Patients

Sophie Le Pogam, A. Seshaadri, Aren Ewing et al. · The Journal of Infectious Diseases · 2010 · 60 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

21 LOW LEVEL OF RESISTANCE, LOW VIRAL FITNESS AND ABSENCE OF RESISTANCE MUTATIONS IN BASELINE QUASISPECIES MAY CONTRIBUTE TO HIGH BARRIER TO R1626 RESISTANCE IN VIVO

Sophie Le Pogam, A. Seshaadri, Hee‐Jin Kang et al. · Journal of Hepatology · 2008 · 13 citations · Full text

Life Sciences, Genetics, Microbiology +8

958 NO EVIDENCE OF R7128 DRUG RESISTANCE AFTER UP TO 4 WEEKS TREATMENT OF GT 1, 2 AND 3 HEPATITIS C VIRUS INFECTED INDIVIDUALS

Sophie Le Pogam, A. Seshaadri, Alan Kosaka et al. · Journal of Hepatology · 2009 · 13 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +12

1–4 of 4